What began in 1998 as a bold vision to improve community wellbeing in the Hunter Region of NSW has today evolved into a world-class institute with 1500 medical researchers, students and support staff striving to prevent, treat and defeat a multitude of serious illnesses.
Delivering patient-focused translational research is our major goal, which means seeding start-up studies and fostering a flow of information and innovation back and forth between scientists, clinicians and public health professionals. Attracting top medical specialists and collaborating with other leading institutes and industries helps to fast-track the provision of new and better health solutions.
HMRI is led by Director Professor Michael Nilsson, a globally recognised neuroscientist and researcher in the field of stroke rehabilitation with a proven track record in building research collaborations and networks. Professor Nilsson serves on the National Health and Medical Research Council’s Health Translation Advisory Committee (HTAC) and is Conjoint Professor of Neurological Rehabilitation at the University of Gothenburg.
In partnership with the University of Newcastle and Hunter New England Local Health District, HMRI’s clinical, biomedical and public health researchers work across multiple campuses and seven key translational research programs:
- Brain and Mental Health
- Information Based Medicine
- Pregnancy and Reproduction
- Public Health
- Viruses, Infections/Immunity, Vaccines and Asthma (VIVA)
HMRI researchers rely on philanthropic donations from the community, along with Australian Government funding, to support research projects, equipment, scholarships, fellowships and travel grants. Internal grant funding is allocated through a rigorous peer-review process and invested in areas of highest public need.
Infrastructure funding is provided by the NSW Office for Medical Research through the Medical Research Support Program, and the NSW Department of Health through the Capacity Building Infrastructure Grant Program.